AAAAAA
Results:
1-25
|
Results: 25
Authors:
LINK KH
LEDER G
PILLASCH J
BUTZER U
STAIB L
KORNMANN M
BRUCKNER U
BEGER HG
Citation: Kh. Link et al., IN-VITRO CONCENTRATION RESPONSE STUDIES AND IN-VITRO PHASE-II TESTS AS THE EXPERIMENTAL BASIS FOR REGIONAL CHEMOTHERAPEUTIC PROTOCOLS, Seminars in surgical oncology, 14(3), 1998, pp. 189-201
Authors:
LINK KH
FORMENTINI A
LEDER G
FORTNAGEL G
SARTORI N
SCHATZ M
BEGER HG
Citation: Kh. Link et al., RESECTION AND RADIOCHEMOTHERAPY OF PANCREATIC-CANCER - THE FUTURE, LANGENBECKS ARCHIVES OF SURGERY, 383(2), 1998, pp. 134-144
Authors:
BEGER HG
LINK KH
GANSAUGE F
Citation: Hg. Beger et al., ADJUVANT REGIONAL CHEMOTHERAPY IN ADVANCED PANCREATIC-CANCER - RESULTS OF A PROSPECTIVE-STUDY, Hepato-gastroenterology, 45(21), 1998, pp. 638-643
Authors:
FORMENTINI A
LINK KH
PILLASCH J
BEGER HG
Citation: A. Formentini et al., A 7-YEARS EXPERIENCE WITH IMPLANTABLE DEVICES FOR REGIONAL HEPATIC ARTERIAL CHEMOTHERAPY - USABILITY TIME, INCIDENCE AND MANAGEMENT OF COMPLICATIONS, European journal of cancer, 33, 1997, pp. 734-734
Authors:
LINK KH
STAIB L
BERNHART H
KREUSER ED
SUHR P
ROTTINGER E
BEGER HG
Citation: Kh. Link et al., INTERIM-REPORT ON TOXICITY AND COMPLIANCE OF THE FOGT-1 AND FOGT-2 TRIALS FOR ADJUVANT POSTOPERATIVE THERAPY IN COLON-CANCER AND RECTAL-CANCER, European journal of cancer, 33, 1997, pp. 1102-1102
Authors:
LEDER GH
LINK KH
FORMENTINI A
WIDMAIER U
PILLASCH J
BEGER HG
Citation: Gh. Leder et al., EFFICACY OF INTRAHEPATIC CHEMOTHERAPY FOR LIVER METASTASES OF RARE GASTROINTESTINAL-TRACT AND OTHER RARE CANCERS, European journal of cancer, 33, 1997, pp. 1278-1278
Authors:
LINK KH
GANSAUGE F
GORICH J
LEDER GH
RILINGER N
BEGER HG
Citation: Kh. Link et al., PALLIATIVE AND ADJUVANT REGIONAL CHEMOTHERAPY IN PANCREATIC-CANCER, European journal of surgical oncology, 23(5), 1997, pp. 409-414
Authors:
LINK KH
STAIB L
BERNHART H
KREUSER ED
SUHR P
ROTTINGER E
BEGER HG
KRAUTZBERGER W
BEWERSDORF H
KAHLE M
SCHWANGHART F
KARN B
SCHMELZ M
RUNKEL N
BAER U
SEMLER P
LUDTKEHANDJERY A
RUPPEL FJ
AUGENSTEIN H
ENGEL R
THOLL U
MEISSNER D
KLIEBISCH S
PAUL U
PLATZ M
SCHMIDT W
KUHLGATZ J
HENZLER M
SCHRAMM H
TEICHER R
STELZER E
BAUMANN W
KURRLE E
BUCHELT L
LIERSCH T
MAO R
HECKER U
WACKE W
GOTH B
BRULLKE N
VOGT J
MEUSEL P
STEINHAUER EU
KNUFERMANN H
LANDES T
VEHLINGKAISER U
SCHENKER U
KOGEL H
JOST KA
MENTZEL M
KUJATH P
ZERBIAN KU
LORENZ S
AHLEMANN LM
MOKROS W
KETTNER E
RIDWELSKI K
ROSCHER R
LANGE J
RATH W
EBERT KH
FISCHER M
SCHERBER A
BECK J
FUHLROTT M
LENZ P
GABRIEL P
BARTEL F
WEISER HF
SCHUTZE F
MULLER C
ALBRECHT J
BOTHIG R
FRANK R
LEIBL B
PATSAS JR
WEBER W
RENDENBACH B
SCHMIDT R
LUTZ M
SCHNEIDERKAPPUS W
SCHNEIDER M
SIMANK P
DISEBASTIANO P
Citation: Kh. Link et al., ACCEPTANCE AND TOXICITY OF POSTOPERATIVE ADJUVANT THERAPY IN COLON AND RECTAL CANCERS - INTERIM REPORT ON THE TRIALS FOGT1 AND FOGT2 OF THEGERMAN SCHUNGSGRUPPE-ONKOLOGIE-GASTROINTESTINALER-TUMOREN (FOGT), Onkologie, 20(3), 1997, pp. 235-238
Authors:
KORNMANN M
LINK KH
LENZ HJ
PILLASCH J
METZGER R
BUTZER U
LEDER GH
WEINDEL M
SAFI F
DANENBERG KD
BEGER HG
DANENBERG PV
Citation: M. Kornmann et al., THYMIDYLATE SYNTHASE IS A PREDICTOR FOR RESPONSE AND RESISTANCE IN HEPATIC-ARTERY INFUSION CHEMOTHERAPY, Cancer letters, 118(1), 1997, pp. 29-35
Authors:
LINK KH
GANSAUGE F
RILINGER N
BEGER HG
Citation: Kh. Link et al., CELIAC ARTERY ADJUVANT CHEMOTHERAPY - RESULTS OF A PROSPECTIVE TRIAL, International journal of pancreatology, 21(1), 1997, pp. 65-69
Authors:
LINK KH
GANSAUGE F
PILLASCH J
BEGER HG
Citation: Kh. Link et al., MULTIMODAL THERAPIES IN DUCTAL PANCREATIC-CANCER - THE FUTURE, International journal of pancreatology, 21(1), 1997, pp. 71-83
Authors:
LINK KH
FORMENTINI A
GANSAUGE F
PAPACHRISTOV E
BEGER HG
Citation: Kh. Link et al., REGIONAL CELIAC ARTERY INFUSION AS ADJUVANT TREATMENT AFTER PANCREATIC-CANCER RESECTION, Digestion, 58(6), 1997, pp. 529-532
Authors:
BEGER HG
SCHOENBERG MH
LINK KH
SAFI F
BERGER D
Citation: Hg. Beger et al., DUODENUM-PRESERVING PANCREATIC HEAD RESECTION - A STANDARD PROCEDURE IN CHRONIC-PANCREATITIS, Chirurg, 68(9), 1997, pp. 874-880
Authors:
LINK KH
KORNMANN M
LEDER GH
BUTZER U
PILLASCH J
STAIB L
GANSAUGE F
BEGER HG
Citation: Kh. Link et al., REGIONAL CHEMOTHERAPY DIRECTED BY INDIVIDUAL CHEMOSENSITIVITY TESTINGIA VITRO - A PROSPECTIVE DECISION-AIDING TRIAL, Clinical cancer research, 2(9), 1996, pp. 1469-1474
Authors:
PORZSOLT F
WIRTH A
MAYERSTEINACKER R
SCHULTE M
NEGRI G
SUHR P
LINK KH
GAUS W
ROTTINGER EM
Citation: F. Porzsolt et al., QUALITY ASSURANCE BY SPECIFICATION AND ACHIEVEMENT OF GOALS IN PALLIATIVE CANCER-TREATMENT, Cancer treatment reviews, 22, 1996, pp. 41-49
Authors:
DAHLBENDER RW
GRUNWALD C
ALLERT G
POKORNY D
LINK KH
KACHELE H
Citation: Rw. Dahlbender et al., ASPECTS OF THE RELATIONSHIPMODEL AND INTE RACTIONMODEL OF THE LIAISON-PSYCHOTHERAPIST IN A SURGICAL-ONCOLOGICAL TEAM, Gruppenpsychotherapie und Gruppendynamik, 32(3), 1996, pp. 235-255
Authors:
GANSAUGE F
LINK KH
RILINGER N
KUNZ R
BEGER HG
Citation: F. Gansauge et al., ADJUVANT REGIONAL CHEMOTHERAPY IN LOCALLY ADVANCED PANCREATIC-CANCER, Chirurg, 67(4), 1996, pp. 362-365
Authors:
GANSAUGE F
GANSAUGE S
PARKER N
BEGER MI
POCH B
LINK KH
SAFI F
BEGER HG
Citation: F. Gansauge et al., CAM-17.1 - A NEW DIAGNOSTIC MARKER IN PANCREATIC-CANCER, British Journal of Cancer, 74(12), 1996, pp. 1997-2002
Authors:
GANSAUGE F
LINK KH
RILINGER N
KUNZ R
BEGER HG
Citation: F. Gansauge et al., REGIONAL CHEMOTHERAPY IN ADVANCED PANCREA TIC-CARCINOMA, Medizinische Klinik, 90(9), 1995, pp. 501-505
Authors:
RILINGER N
GANZAUGE F
LINK KH
GOERICH J
BEGER H
BRAMBS HJ
Citation: N. Rilinger et al., LOCAL CYTOTOXIC THERAPY IN ADVANCED PANCREATIC-CANCER - EXPERIENCE WITH 210 PROCEDURES, Radiology, 197, 1995, pp. 379-379
Authors:
GANSAUGE F
GANSAUGE S
ZOBYWALSKI A
SCHARNWEBER C
LINK KH
NUSSLER AK
BEGER HG
Citation: F. Gansauge et al., DIFFERENTIAL EXPRESSION OF CD44 SPLICE VARIANTS IN HUMAN PANCREATIC ADENOCARCINOMA AND IN NORMAL PANCREAS, Cancer research, 55(23), 1995, pp. 5499-5503
Authors:
PORZSOLT F
WIRTH A
MAYERSTEINACKER R
SUHR P
WARSZAWSKI N
SCHULTE M
NEGRI G
KLEEBERGER L
LINK KH
BETZ E
SARKAR MR
ROTTINGER E
Citation: F. Porzsolt et al., QUALITY ASSURANCE IN ONCOLOGY - DEFINITION OF TREATMENT GOAL AND ASSESSMENT OF ITS ACHIEVEMENT, Onkologie, 17(4), 1994, pp. 454-457
Authors:
BERGER HG
EIGLER FW
ENGELHARDT R
HARTUNG G
HERFARTH C
HERMANEK P
HERRMANN R
HOSSFELD DK
JUNGINGER T
KIRCHNER R
KREUSER E
LAFFER U
LINK KH
MEYER HJ
PICHLMAIER H
QUEISSER W
RAAB HR
SAUER R
SCHEIBE O
SCHMOLL HJ
STOCK W
WILKE H
Citation: Hg. Berger et al., ADJUVANT THERAPY FOR PATIENTS WITH COLON AND RECTAL-CANCER - CONSENSUS OF CAO, AIO AND ARO, Onkologie, 17(3), 1994, pp. 291-293
Authors:
LINK KH
KREUSER ED
SAFI F
ULLRICH J
SCHALHORN A
SCHMOLL E
BEGER HG
Citation: Kh. Link et al., THE STATUS OF 5-FU AND FOLINIC ACID (FA, RESCUVOLIN(R)) IN THE TREATMENT CONCEPT OF NONRESECTABLE COLORECTAL LIVER METASTASES - A COMPARISON OF 5-FU FA IA VS 5-FU/FA IV VS 5-FUDR IA VS 5-FUDR IA+IV IN AN OBSERVATION STUDY/, Tumordiagnostik & Therapie, 14(6), 1993, pp. 224-231
Authors:
SAFI F
LINK KH
BEGER HG
Citation: F. Safi et al., IS FOLLOW-UP OF COLORECTAL-CANCER PATIENTS WORTHWHILE, Diseases of the colon & rectum, 36(7), 1993, pp. 636-642
Risultati:
1-25
|